HeartSciences
HSCS | NASDAQ
$2.08
-$0.04 (-2.12%)
At close: Nov 16, 2026, 4:00 PM ET
$2.03
-$0.05 (-2.40%)
After-hours:
Nov 16, 2026, 4:31 PM ET
HeartSciences Company Profile
Company profile explainedCompany Profile
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.
Key Executives
| Name | Position |
|---|---|
| Andrew Simpson | Chief Executive Officer, President & Chairman of the Board of Directors |
| Danielle Watson | Chief Financial Officer & Treasurer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | DEFA14A | Filing |
| Oct 29, 2026 | DEFA14A | Filing |
| Oct 28, 2026 | DEFA14A | Filing |
| Oct 28, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 27, 2026 | DEFA14A | Filing |
| Oct 26, 2026 | DEFA14A | Filing |
| Oct 26, 2026 | DEFA14A | Filing |
| Oct 23, 2026 | SC 13D/A | [Amend] Filing |
| Oct 21, 2026 | DEFA14A | Filing |
| Oct 19, 2026 | DEFA14A | Filing |
HeartSciences
| Country | United States |
| IPO Date | Jun 16, 2022 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Andrew Simpson |
Contact Details
550 Reserve Street Southlake,
Texas 76092 United States
Stock Details
| Ticker Symbol | HSCS |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| CIK Code | 0001468492 |
| CUSIP Number | 42254E302 |
| ISIN Number | US42254E3027 |
| SIC Code | 3842 |
Add to Watchlist
Select watchlists to add or remove HSCS